|
a |
|
b/processing/MACCROBAT/19860007.ann |
|
|
1 |
T1 Age 2 13 70-year-old |
|
|
2 |
T2 Sex 14 17 man |
|
|
3 |
T3 Clinical_event 22 30 referred |
|
|
4 |
E1 Clinical_event:T3 |
|
|
5 |
T4 Nonbiological_location 38 46 hospital |
|
|
6 |
T5 Biological_structure 51 58 gastric |
|
|
7 |
T6 Disease_disorder 59 65 cancer |
|
|
8 |
E2 Disease_disorder:T6 |
|
|
9 |
R1 MODIFY Arg1:T5 Arg2:E2 |
|
|
10 |
T7 Diagnostic_procedure 104 130 esophagogastroduodenoscopy |
|
|
11 |
E3 Diagnostic_procedure:T7 |
|
|
12 |
T8 Diagnostic_procedure 131 136 (EGD) |
|
|
13 |
E4 Diagnostic_procedure:T8 |
|
|
14 |
R2 IDENTICAL Arg1:E4 Arg2:E3 |
|
|
15 |
T9 History 138 168 No significant medical history |
|
|
16 |
T10 Sign_symptom 192 199 dysuria |
|
|
17 |
E5 Sign_symptom:T10 |
|
|
18 |
T11 Detailed_description 200 229 caused by bladder contraction |
|
|
19 |
R3 MODIFY Arg1:T11 Arg2:E5 |
|
|
20 |
T12 Diagnostic_procedure 239 249 laboratory |
|
|
21 |
E6 Diagnostic_procedure:T12 |
|
|
22 |
T13 Diagnostic_procedure 264 282 serum level of AFP |
|
|
23 |
E7 Diagnostic_procedure:T13 |
|
|
24 |
T14 Lab_value 286 296 32.3 ng/mL |
|
|
25 |
R4 MODIFY Arg1:T14 Arg2:E7 |
|
|
26 |
R5 SUB_PROCEDURE Arg1:E7 Arg2:E6 |
|
|
27 |
T15 Diagnostic_procedure 396 420 carcinoembryonic antigen |
|
|
28 |
E8 Diagnostic_procedure:T15 |
|
|
29 |
T16 Diagnostic_procedure 421 426 (CEA) |
|
|
30 |
E9 Diagnostic_procedure:T16 |
|
|
31 |
T17 Diagnostic_procedure 431 456 carbohydrate antigen 19-9 |
|
|
32 |
E10 Diagnostic_procedure:T17 |
|
|
33 |
T18 Diagnostic_procedure 457 465 (CA19-9) |
|
|
34 |
E11 Diagnostic_procedure:T18 |
|
|
35 |
R6 IDENTICAL Arg1:E11 Arg2:E10 |
|
|
36 |
R7 IDENTICAL Arg1:E9 Arg2:E8 |
|
|
37 |
R8 SUB_PROCEDURE Arg1:E8 Arg2:E6 |
|
|
38 |
R9 SUB_PROCEDURE Arg1:E10 Arg2:E6 |
|
|
39 |
T19 Lab_value 329 349 no other abnormality |
|
|
40 |
R10 MODIFY Arg1:T19 Arg2:E8 |
|
|
41 |
R11 MODIFY Arg1:T19 Arg2:E10 |
|
|
42 |
T20 Coreference 467 470 EGD |
|
|
43 |
E12 Coreference:T20 |
|
|
44 |
R12 IDENTICAL Arg1:E12 Arg2:E3 |
|
|
45 |
T21 Sign_symptom 503 507 mass |
|
|
46 |
E13 Sign_symptom:T21 |
|
|
47 |
T22 Detailed_description 487 502 ulcerofungating |
|
|
48 |
R13 MODIFY Arg1:T22 Arg2:E13 |
|
|
49 |
T23 Distance 482 486 5-cm |
|
|
50 |
R14 MODIFY Arg1:T23 Arg2:E13 |
|
|
51 |
T24 Detailed_description 517 550 comprised of three septate ulcers |
|
|
52 |
R15 MODIFY Arg1:T24 Arg2:E13 |
|
|
53 |
T25 Biological_structure 551 597 in the greater curvature of the gastric antrum |
|
|
54 |
R16 MODIFY Arg1:T25 Arg2:E13 |
|
|
55 |
T26 Diagnostic_procedure 601 625 pathological examination |
|
|
56 |
E14 Diagnostic_procedure:T26 |
|
|
57 |
T27 Biological_structure 629 654 endoscopic biopsy tissues |
|
|
58 |
T28 Disease_disorder 715 729 adenocarcinoma |
|
|
59 |
E15 Disease_disorder:T28 |
|
|
60 |
T29 Detailed_description 707 714 tubular |
|
|
61 |
R17 MODIFY Arg1:T29 Arg2:E15 |
|
|
62 |
T30 Detailed_description 681 706 moderately differentiated |
|
|
63 |
R18 MODIFY Arg1:T30 Arg2:E15 |
|
|
64 |
R19 MODIFY Arg1:T27 Arg2:E14 |
|
|
65 |
R20 MODIFY Arg1:E15 Arg2:E14 |
|
|
66 |
T31 Diagnostic_procedure 757 776 computed tomography |
|
|
67 |
E16 Diagnostic_procedure:T31 |
|
|
68 |
T32 Biological_structure 742 756 abdominopelvic |
|
|
69 |
R21 MODIFY Arg1:T32 Arg2:E16 |
|
|
70 |
T33 Sign_symptom 798 802 mass |
|
|
71 |
E17 Sign_symptom:T33 |
|
|
72 |
T34 Biological_structure 790 797 gastric |
|
|
73 |
R22 MODIFY Arg1:T34 Arg2:E17 |
|
|
74 |
R23 MODIFY Arg1:E17 Arg2:E16 |
|
|
75 |
T35 Detailed_description 803 823 with deep ulceration |
|
|
76 |
R24 MODIFY Arg1:T35 Arg2:E17 |
|
|
77 |
T36 Biological_structure 824 845 in the gastric antrum |
|
|
78 |
R25 MODIFY Arg1:T36 Arg2:E17 |
|
|
79 |
T37 Detailed_description 846 885 with perigastric lymph node enlargement |
|
|
80 |
R26 MODIFY Arg1:T37 Arg2:E17 |
|
|
81 |
T38 Sign_symptom 890 908 metastatic lesions |
|
|
82 |
E18 Sign_symptom:T38 |
|
|
83 |
A1 POLARITY E18 NEG |
|
|
84 |
T39 Biological_structure 930 935 liver |
|
|
85 |
T40 Biological_structure 937 941 lung |
|
|
86 |
T41 Biological_structure 945 955 peritoneum |
|
|
87 |
R27 MODIFY Arg1:T39 Arg2:E18 |
|
|
88 |
R28 MODIFY Arg1:T40 Arg2:E18 |
|
|
89 |
R29 MODIFY Arg1:T41 Arg2:E18 |
|
|
90 |
T42 Biological_structure 961 966 chest |
|
|
91 |
T43 Diagnostic_procedure 967 978 radiography |
|
|
92 |
E19 Diagnostic_procedure:T43 |
|
|
93 |
R30 MODIFY Arg1:T42 Arg2:E19 |
|
|
94 |
T44 Sign_symptom 986 1009 no significant findings |
|
|
95 |
E20 Sign_symptom:T44 |
|
|
96 |
R31 MODIFY Arg1:E20 Arg2:E19 |
|
|
97 |
T45 Therapeutic_procedure 1028 1039 gastrectomy |
|
|
98 |
E21 Therapeutic_procedure:T45 |
|
|
99 |
T46 Detailed_description 1011 1018 Radical |
|
|
100 |
T47 Detailed_description 1019 1027 subtotal |
|
|
101 |
R32 MODIFY Arg1:T47 Arg2:E21 |
|
|
102 |
R33 MODIFY Arg1:T46 Arg2:E21 |
|
|
103 |
T48 Biological_structure 1045 1058 D2 lymph node |
|
|
104 |
T49 Therapeutic_procedure 1059 1069 dissection |
|
|
105 |
E22 Therapeutic_procedure:T49 |
|
|
106 |
T50 Therapeutic_procedure 1086 1103 gastrojejunostomy |
|
|
107 |
E23 Therapeutic_procedure:T50 |
|
|
108 |
T51 Detailed_description 1074 1085 Billroth II |
|
|
109 |
R34 MODIFY Arg1:T48 Arg2:E22 |
|
|
110 |
R35 MODIFY Arg1:T51 Arg2:E23 |
|
|
111 |
R36 SUB_PROCEDURE Arg1:E22 Arg2:E21 |
|
|
112 |
R37 SUB_PROCEDURE Arg1:E23 Arg2:E21 |
|
|
113 |
T52 Therapeutic_procedure 2366 2386 postoperative course |
|
|
114 |
E24 Therapeutic_procedure:T52 |
|
|
115 |
T53 Lab_value 2355 2365 uneventful |
|
|
116 |
R38 MODIFY Arg1:T53 Arg2:E24 |
|
|
117 |
T54 Clinical_event 2395 2405 discharged |
|
|
118 |
E25 Clinical_event:T54 |
|
|
119 |
T55 Date 2409 2428 postoperative day 9 |
|
|
120 |
E26 Date:T55 |
|
|
121 |
T56 Date 2430 2445 Two weeks later |
|
|
122 |
E27 Date:T56 |
|
|
123 |
T57 Diagnostic_procedure 2451 2460 HCG level |
|
|
124 |
E28 Diagnostic_procedure:T57 |
|
|
125 |
T58 Lab_value 2465 2475 176 mIU/mL |
|
|
126 |
R39 MODIFY Arg1:T58 Arg2:E28 |
|
|
127 |
T59 Diagnostic_procedure 2512 2521 AFP level |
|
|
128 |
E29 Diagnostic_procedure:T59 |
|
|
129 |
T60 Lab_value 2526 2536 10.0 ng/mL |
|
|
130 |
R40 MODIFY Arg1:T60 Arg2:E29 |
|
|
131 |
T61 Medication 2552 2573 adjuvant chemotherapy |
|
|
132 |
E30 Medication:T61 |
|
|
133 |
T62 Medication 2579 2591 capecitabine |
|
|
134 |
E31 Medication:T62 |
|
|
135 |
R41 MODIFY Arg1:E31 Arg2:E30 |
|
|
136 |
T63 Frequency 2538 2548 Six cycles |
|
|
137 |
R42 MODIFY Arg1:T63 Arg2:E30 |
|
|
138 |
T64 Dosage 2657 2690 2500 mg/m2 per day for 14 d/cycle |
|
|
139 |
R43 MODIFY Arg1:T64 Arg2:E31 |
|
|
140 |
T65 Date 2692 2708 After two cycles |
|
|
141 |
E32 Date:T65 |
|
|
142 |
T66 Diagnostic_procedure 2714 2725 β-HCG level |
|
|
143 |
E33 Diagnostic_procedure:T66 |
|
|
144 |
T67 Lab_value 2742 2752 < 3 mIU/mL |
|
|
145 |
R44 MODIFY Arg1:T67 Arg2:E33 |
|
|
146 |
T68 Sign_symptom 2795 2805 recurrence |
|
|
147 |
E34 Sign_symptom:T68 |
|
|
148 |
T69 Sign_symptom 2809 2827 distant metastasis |
|
|
149 |
E35 Sign_symptom:T69 |
|
|
150 |
T70 Date 2848 2854 4-year |
|
|
151 |
E36 Date:T70 |
|
|
152 |
T71 Clinical_event 2855 2878 postoperative follow-up |
|
|
153 |
E37 Clinical_event:T71 |
|
|
154 |
T72 Biological_structure 1133 1150 resected specimen |
|
|
155 |
T73 Sign_symptom 1168 1175 lesions |
|
|
156 |
E38 Sign_symptom:T73 |
|
|
157 |
T74 Lab_value 1161 1167 double |
|
|
158 |
R45 MODIFY Arg1:T74 Arg2:E38 |
|
|
159 |
T75 Detailed_description 1191 1243 a 5.8 cm × 3.2 cm ulcerofungating mass in the antrum |
|
|
160 |
T76 Detailed_description 1250 1270 extensive hemorrhage |
|
|
161 |
R46 MODIFY Arg1:T75 Arg2:E38 |
|
|
162 |
R47 MODIFY Arg1:T76 Arg2:E38 |
|
|
163 |
T77 Detailed_description 1286 1294 fibrosis |
|
|
164 |
R48 MODIFY Arg1:T77 Arg2:E38 |
|
|
165 |
T78 Color 1275 1285 light gray |
|
|
166 |
R49 MODIFY Arg1:T78 Arg2:T77 |
|
|
167 |
T79 Detailed_description 1315 1357 a nearby 2.5 cm × 2.0 cm ulcerative lesion |
|
|
168 |
R50 MODIFY Arg1:T79 Arg2:E38 |
|
|
169 |
T80 Sign_symptom 1428 1439 tumor cells |
|
|
170 |
E39 Sign_symptom:T80 |
|
|
171 |
T81 Detailed_description 1420 1427 bizarre |
|
|
172 |
T82 Detailed_description 1407 1418 pleomorphic |
|
|
173 |
T83 Lab_value 1388 1403 massive numbers |
|
|
174 |
R51 MODIFY Arg1:T83 Arg2:E39 |
|
|
175 |
R52 MODIFY Arg1:T81 Arg2:E39 |
|
|
176 |
R53 MODIFY Arg1:T82 Arg2:E39 |
|
|
177 |
T84 Detailed_description 1445 1499 hemorrhage (syncytiotrophoblasts and cytotrophoblasts) |
|
|
178 |
R54 MODIFY Arg1:T84 Arg2:E39 |
|
|
179 |
T85 Diagnostic_procedure 1535 1577 Hematoxylin and eosin (HE)-stained tissues |
|
|
180 |
E40 Diagnostic_procedure:T85 |
|
|
181 |
T86 Biological_structure 1603 1612 cytoplasm |
|
|
182 |
T87 Color 1596 1602 purple |
|
|
183 |
T88 Shape 1589 1595 bubbly |
|
|
184 |
R55 MODIFY Arg1:T87 Arg2:T86 |
|
|
185 |
R56 MODIFY Arg1:T88 Arg2:T86 |
|
|
186 |
T89 Biological_structure 1623 1629 nuclei |
|
|
187 |
T90 Detailed_description 1635 1656 magnification of 40 × |
|
|
188 |
T91 Detailed_description 1674 1679 100 × |
|
|
189 |
R57 MODIFY Arg1:T90 Arg2:E40 |
|
|
190 |
R58 MODIFY Arg1:T91 Arg2:E40 |
|
|
191 |
R59 MODIFY Arg1:T86 Arg2:E40 |
|
|
192 |
R60 MODIFY Arg1:T89 Arg2:E40 |
|
|
193 |
T92 Lab_value 1617 1622 giant |
|
|
194 |
R61 MODIFY Arg1:T92 Arg2:T89 |
|
|
195 |
T93 Coreference 1698 1703 tumor |
|
|
196 |
E41 Coreference:T93 |
|
|
197 |
R62 IDENTICAL Arg1:E41 Arg2:E39 |
|
|
198 |
T94 Biological_structure 1717 1742 proper muscle layer (T2a) |
|
|
199 |
R63 MODIFY Arg1:T94 Arg2:E41 |
|
|
200 |
T95 Sign_symptom 1747 1757 metastasis |
|
|
201 |
E42 Sign_symptom:T95 |
|
|
202 |
T96 Biological_structure 1768 1802 in four of 56 regional lymph nodes |
|
|
203 |
R64 MODIFY Arg1:T96 Arg2:E42 |
|
|
204 |
T97 Diagnostic_procedure 1809 1837 Immunohistochemical staining |
|
|
205 |
E43 Diagnostic_procedure:T97 |
|
|
206 |
T98 Lab_value 1845 1870 positive immunoreactivity |
|
|
207 |
T99 Diagnostic_procedure 1875 1905 β-human chorionic gonadotropin |
|
|
208 |
E44 Diagnostic_procedure:T99 |
|
|
209 |
T100 Diagnostic_procedure 1950 1953 AFP |
|
|
210 |
E45 Diagnostic_procedure:T100 |
|
|
211 |
T101 Lab_value 1929 1945 focal positivity |
|
|
212 |
R65 MODIFY Arg1:T101 Arg2:E45 |
|
|
213 |
R66 MODIFY Arg1:T98 Arg2:E44 |
|
|
214 |
R67 SUB_PROCEDURE Arg1:E44 Arg2:E43 |
|
|
215 |
R68 SUB_PROCEDURE Arg1:E45 Arg2:E43 |
|
|
216 |
T102 Disease_disorder 2017 2032 choriocarcinoma |
|
|
217 |
E46 Disease_disorder:T102 |
|
|
218 |
T103 Biological_structure 2009 2016 gastric |
|
|
219 |
R69 MODIFY Arg1:T103 Arg2:E46 |
|
|
220 |
T104 Disease_disorder 2151 2165 adenocarcinoma |
|
|
221 |
E47 Disease_disorder:T104 |
|
|
222 |
T105 Biological_structure 2143 2150 tubular |
|
|
223 |
T106 Disease_disorder 2079 2093 adenocarcinoma |
|
|
224 |
E48 Disease_disorder:T106 |
|
|
225 |
T107 Detailed_description 2065 2078 AFP-producing |
|
|
226 |
R70 MODIFY Arg1:T107 Arg2:E48 |
|
|
227 |
R71 MODIFY Arg1:T105 Arg2:E47 |
|
|
228 |
T108 Biological_structure 2173 2205 extended to the submucosal layer |
|
|
229 |
R72 MODIFY Arg1:T108 Arg2:E47 |
|
|
230 |
R73 MODIFY Arg1:T4 Arg2:E1 |
|
|
231 |
* OVERLAP E1 E2 E3 |
|
|
232 |
R74 AFTER Arg1:E3 Arg2:E5 |
|
|
233 |
R75 BEFORE Arg1:E5 Arg2:E6 |
|
|
234 |
* OVERLAP E6 E12 E13 E14 E15 |
|
|
235 |
R76 BEFORE Arg1:E15 Arg2:E16 |
|
|
236 |
* OVERLAP E16 E17 E18 E19 E20 |
|
|
237 |
R77 BEFORE Arg1:E20 Arg2:E21 |
|
|
238 |
R78 BEFORE Arg1:E21 Arg2:E38 |
|
|
239 |
R79 MODIFY Arg1:T72 Arg2:E38 |
|
|
240 |
* OVERLAP E38 E39 E40 E42 E41 E43 E46 E48 E47 |
|
|
241 |
R80 BEFORE Arg1:E47 Arg2:E24 |
|
|
242 |
R81 BEFORE Arg1:E24 Arg2:E25 |
|
|
243 |
* OVERLAP E25 E26 |
|
|
244 |
R82 BEFORE Arg1:E26 Arg2:E27 |
|
|
245 |
* OVERLAP E27 E28 E29 |
|
|
246 |
R83 BEFORE Arg1:E29 Arg2:E30 |
|
|
247 |
R84 BEFORE Arg1:E30 Arg2:E32 |
|
|
248 |
* OVERLAP E32 E33 |
|
|
249 |
R85 BEFORE Arg1:E33 Arg2:E34 |
|
|
250 |
A2 POLARITY E34 NEG |
|
|
251 |
A3 POLARITY E35 NEG |
|
|
252 |
* OVERLAP E34 E35 E36 E37 |
|
|
253 |
T109 Lab_value 2730 2738 declined |
|
|
254 |
E49 Lab_value:T109 |
|
|
255 |
R86 MODIFY Arg1:E49 Arg2:E33 |